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M A J O R A R T I C L E
Functional Tumor Necrosis Factor–Related
Apoptosis-Inducing Ligand Production
by Avian Influenza Virus–Infected Macrophages
Jianfang Zhou,1 Helen K. W. Law,1 Chung Yan Cheung,2 Iris H. Y. Ng,2 J. S. Malik Peiris,2 and Yu Lung Lau1
Departments of 1Paediatrics and Adolescent Medicine and 2Microbiology, Hong Kong Jockey Club Clinical Research Centre, Faculty of Medicine,
The University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, China
Severe human disease associated with influenza A H5N1 virus was first detected in Hong Kong in 1997. Its
recent reemergence in Asia and high associated mortality highlight the need to understand its pathogenesis.
We investigated the roles of death receptor ligands (DRLs) in H5N1 infection. Significant up-regulation of
tumor necrosis factor (TNF)–related apoptosis-inducing ligand (TRAIL) and TNF-a, but not Fas ligand (FasL)
mRNA, was detected in human monocyte–derived macrophages (MDMs) infected with avian influenza viruses
A/Hong Kong/483/97 (H5N1/97) or its precursor, A/Quail/Hong Kong/G1/97. H5N1/97-infected MDMs ex-
hibited the strongest induction of apoptosis in Jurkat T cells, and it could be reduced by TRAIL–receptor 2
blocking antibody. Furthermore, influenza virus infection enhanced the sensitivity of Jurkat T cells to apoptosis
induced by TNF-a, TRAIL, and FasL. Our data suggested that functional TRAIL produced by influenza virus–
infected MDMs was related to their cytotoxicity and that the enhanced sensitization to DRL-induced apoptosis
detected in avian influenza may contribute to disease pathogenesis.
In 1997, the avian influenza virus H5N1 crossed the
species barrier and caused 18 confirmed human infec-
tions in Hong Kong with a case-fatality rate of 33%.
The clinical manifestations include lymphopenia and
severe pneumonia progressing to the syndromes of
acute respiratory distress and multiple organ dysfunc-
tion [1, 2]. The proinflammatory cytokine dysregula-
tion detected in human H5N1 disease is thought to
contribute to the severity of this influenza [3]. However,
the immune response in human to the avian influenza
virus remains unclear.
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It has been shown in mallard ducks that H5N1 vi-
rus enhances macrophage phagocytic activity but sup-
presses T cell function [4]. In mice, H5N1 virus de-
pleted lymphocytes through apoptosis, which resulted
in the reduction of interferon (IFN)–g, interleukin (IL)–
1b, macrophage inflammatory protein, and tissue cel-
lularity, leading to a higher mortality rate [5]. Indeed,
cross-reactive cytotoxic T lymphocyte responses have
been observed in humans with no previous exposure
to avian influenza virus [6], and B cell–dependent het-
erosubtypic cross-protection against H5N1 virus could
also be induced in mice [7]. Because lymphopenia is a
notable observation in H5N1 infection, the clinical se-
verity of human disease is associated with low periph-
eral white blood cell and lymphocyte counts at admis-
sion [1, 2, 8, 9], the induction of lymphocyte apoptosis
may contribute to disease pathogenesis.
Death receptors (DRs) and their ligands play im-
portant roles in orchestrating innate and adaptive im-
mune responses against pathogens by regulating cell
death and survival [10]. Tumor necrosis factor (TNF)–
related apoptosis-inducing ligand (TRAIL) is a member
of the TNF superfamily and was identified by sequence
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Table 1. Primer sequences and probes used in real-time polymerase chain reaction.
Gene, primer and probe sequence
Amplification
product
length, bp
GenBank
accession no.
TNF-a 84 gi20381341
F, 5′-CCC AGG GAC CTC TCT CTA ATC
R, 5′-AGT GAC AAG CCT GTA GCC CAT
P, 5′-(FAM) TGG CCC AGG CAG TCA GAT CAT C (TAMRA)
TRAIL 74 U57059
F, 5′-CCC CTG CTG GCA AGT CAA
R, 5′-GAG GTT GCA GTG GTG AGA
P, 5′-(FAM) TGG CAA CTC CGT CAG CTC GTT (TAMRA)
FasL 170 gi4557328
F, 5′-ACC TCA AGG GGG ACT GTC TTT
R, 5′-AAT CAA GTG GCT ACC GAG
P, 5′-(FAM) ACA TGG TTG TGA CCT GAG GAT TTA AGG GAT GG (TAMRA)
b-actin 90 gi33988640
F, 5′-GGA TGC AGA AGG AGA TCA CTG
R, 5′-CAA GTA CTC CGTGTG GAT CG
P, 5′-(FAM) CCC TGG CAC CCA GCA CAA TGA (TAMRA)
NOTE. F, forward; FasL, Fas ligand; P, Taqman probes; R, reverse; TNF, tumor necrosis factor; TRAIL, TNF-related apoptosis-
inducing ligand.
homology with 2 well-characterized DR ligands (DRLs), TNF-
a and Fas ligand (FasL). There are 5 receptors (R) for TRAIL,
of which TRAIL-R1 and TRAIL-R2 contain the death domains.
The binding of DRLs to their specific receptors leads to the
activation of a cascade of specific proteolytic enzymes (termed
“caspases”), leading to apoptosis [11]. Several viruses—includ-
ing measles virus, HIV, cytomegalovirus, papillomavirus, and
herpes simplex virus—trigger immune-cell cytotoxicity through
the induction of TRAIL expression, which is involved in the
killing of virus-infected cells or bystander lymphocytes and NK
cells [12–16]. However, little is known about the apoptosis of
immune cells mediated by DRLs, particularly TRAIL, in H5N1
infection.
We have previously reported that avian influenza virus
H5N1/97—but not the human strains A/Hong Kong/54/98
(H1N1) and A/Hong Kong/1174/99 (H3N2)—could induce
high production of proinflammatory cytokines, most notably
TNF-a, in human primary macrophages [3]. The precursor of
H5N1 virus, A/Quail/Hong Kong/G1/97 (H9N2/G1), which
shares 6 internal gene segments with H5N1/97, also shared the
high cytokine induction phenotype [3, 17]. In the present study,
we hypothesized that the innate immune responses to H5N1
result in a strong expression of DRLs that lead to lymphocyte
apoptosis. Using Jurkat T cells as a model, we demonstrate the
release of functional TRAIL and cytotoxicity of H5N1/97- or
H9N2/G1-infected macrophages.
MATERIALS AND METHODS
Cells. Human monocyte-derived macrophages (MDMs) were
generated from buffy coats of samples from healthy blood do-
nors as described elsewhere [3]. The research protocol was
approved by the Institutional Review Board of The University
of Hong Kong/Hospital Authority Hong Kong West Cluster.
The purity of monocytes, as determined by flow cytometry
(Coulter Epics Elite; Beckman Coulter) with anti-CD14 mono-
clonal antibody (BD PharMingen), was consistently 190%. The
monocytes were refed by fresh medium every 2 days and al-
lowed to differentiate for 14 days in vitro.
The Jurkat T cell line (American Type Culture Collection
[ATCC]) was maintained in RPMI 1640 medium (Invitrogen
Life Technologies) with 10% fetal bovine serum (FBS; Invitro-
gen Life Technologies). MDCK cells (ATCC) and murine fi-
broblasts L929 (ATCC) were cultured in MEM (Invitrogen Life
Technologies) supplemented with 10% FBS.
Virus preparation, titration, and infection. In view of the
biosafety issues involved in handling highly pathogenic viruses,
we used avian influenza virus H9N2/G1 for optimization of
the experimental system. Then, findings obtained with H9N2/
G1 were confirmed using H5N1/97 virus in a biohazard level
3 facility. Avian influenza virus H9N2/G1 and human influenza
A virus 54/98 (H1N1/98) were grown in MDCK cells that con-
tained 2 mg/L N-p-tosyl-L-phenylalaninechloromethyl ketone–
treated (TPCK) trypsin (Sigma). H5N1/97 virus was propagated
in MDCK cells without TPCK trypsin, because these highly
pathogenic avian influenza viruses are not dependent on ex-
ogenously added trypsin for productive virus replication. Virus
stocks were purified by adsorption to and elution from turkey
red blood cells [18] and were stored at 70C until use. The
titer of virus stock was determined by daily observation for
cytopathic effect in MDCK cells and confirmed by hemagglu-
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Figure 1. mRNA expression of tumor necrosis factor (TNF)–a, TNF-related apoptosis-inducing ligand (TRAIL), and Fas ligand (FasL) in influenza virus–
infected monocyte-derived macrophages (MDMs). A, B, and C, The kinetics of TNF-a, TRAIL, and FasL mRNA expression in H1N1/98- and H9N2/G1-
infected MDMs. Total RNA was harvested at 4, 8, and 12 h after influenza virus infection. The target genes were quantified by quantitative reverse-
transcription polymerase chain reaction and normalized to copies of b-actin mRNA. Data are the mean  SE from 6 independent experiments.41 10
D, E, and F, TNF-a, TRAIL, and FasL mRNA expression in MDMs treated by H5N1 and UV-irradiated H5N1 (UVH1N1) at 7 h after infection. Data are
the mean  SE from 4 independent experiments. * , ** .P ! .05 P ! .01
tination assay [19]. To inactivate viruses, samples were irra-
diated at a dose of 0.2 J/cm2 for 15 min in a UV cross-linker
(Spectrolinker).
Day-14 differentiated MDMs and Jurkat T cells were infected
by influenza viruses at MOIs of 2 and 1, respectively. This was
set as the 0-h point of infection (POI) for the experiments
described below. After virus adsorption for 1 h at 37C, un-
adsorbed virus was removed by washing with PBS. Mock-
treated cells were handled in parallel, except that virus was not
added. To determine infectivity, cells were fixed and analyzed
by immunofluorescent staining specific for influenza A virus
nucleoprotein (DAKO Imagen; Dako Diagnostics).
Quantification of mRNA by real-time, quantitative reverse-
transcription (RT) polymerase chain reaction (PCR). Infected
MDMs (∼ ) cultured in macrophage serum-free me-55 10
dium (Invitrogen Life Technologies) were harvested at the 4-,
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Figure 2. Sensitivity of Jurkat T cells to tumor necrosis factor (TNF)–
related apoptosis-inducing ligand (TRAIL)– and Fas ligand (FasL)–induced
apoptosis but not to TNF-a. A, Jurkat T cells cultured in the presence
of recombinant TNF-a, TRAIL, and FasL at concentrations of 0–100 ng/
mL for 24 h. Cell death was determined by active caspase–3 staining.
B, Jurkat T cell death, induced by 100 ng/mL recombinant human (rh)
TRAIL and 100 ng/mL FasL and inhibited by specific antibodies at a final
concentration of 1 mg/mL. Data are representative of 3 independent
experiments. TRAIL-R2, TRAIL receptor 2.
8-, and 12-h POI for total RNA extraction by TRIzol Reagent
(Invitrogen Life Technologies). RT was performed on DNase-
treated total RNA. The cDNA was synthesized from mRNA
with oligo(dT)12–18 primer and Superscript II reverse transcrip-
tase (Invitrogen Life Technologies). The cDNA samples were
diluted (1:10) and used as the template. Specific primers and
probes (table 1) were used in a real-time PCR assay (ABI PRISM
7700 Sequence Detection System; Applied Biosystem). The
standard curve was generated using serial dilutions of plasmids
(∼10–107 copies) that contained the respective cloned gene tar-
gets. The results were normalized and expressed as the number
of target gene copies per 104 copies of b-actin.
Bioassay for TNF-a in the culture supernatants from virus-
infected MDMs. To avoid the generation of aerosol, we used
a sensitive bioassay for quantitating bioactive TNF-a in culture
supernatants [20]. Some samples were being assayed by both
bioassay and ELISA, and a strong correlation was observed
(data not shown). Supernatants from mock- or virus-infected
106 MDMs/well in a volume of 800 mL of RPMI 1640 plus 10%
FBS for 24 h were collected and stored at 70C, thawed, and
UV irradiated before use.
The culture supernatants or samples diluted to 1:10 or 1:
50 were added into a confluent culture of L929 cells in 96-well
plate with 1 mg/mL actinomycin D (Sigma) in duplicate, and
cell viability was determined by crystal violet staining. The con-
centration of TNF-a in the supernatants was calculated with
reference to the standard curve generated by serial dilution of
recombinant human TNF-a (R & D Systems).
Apoptosis of T lymphocytes by culture supernatants from
virus-infected MDMs. Jurkat T cells ( /mL) were cul-55 10
tured in the presence of 50% UV-treated culture supernatants
generated from mock- or virus-infected MDMs for 24 h. The
cell death was detected by anti–active caspase–3 antibody stain-
ing (BD PharMingen), as described in our previous study [21].
The experiments were also performed in the presence of 1 mg/
mL TRAIL-R2/Fc chimera (631-T2; R & D Systems) for the
blocking of TRAIL or 1 mg/mL neutralizing anti–FasL antibody
(clone 100419; R & D Systems) for the determination of the
specific pathway of apoptosis. The optimal concentration used
was determined by titration.
Coculture of PKH-26–labeled Jurkat T cells with virus-in-
fected MDMs. To distinguish between effector and target cells,
Jurkat T cells were labeled with PKH-26 (Sigma) before co-
culture at a MDMs:Jurkat T cell ratio of 2:1 for a further 24
h. The experiments were also performed in the presence of
TRAIL-R2/Fc chimera (1 mg/mL) or anti-FasL (1 mg/mL). Then,
cell death was detected by active caspase–3 staining, as described
above. To ensure that H1N1/98 and H9N2/G1 released by in-
fected MDMs would not infect the Jurkat T cells, TPCK trypsin
was not added to the coculture system.
Statistical analysis. Data are expressed as means  SEs.
Statistical significance was determined by Student t test or the
nonparametric equivalent, the Mann-Whitney U test, using In-
stat software (version 3.05; GraphPad). was consideredP ! .05
to be significant.
RESULTS
Up-regulation of the expression of TNF-a and TRAIL but not
FasL mRNA in MDMs by avian influenza virus infection.
MDMs are susceptible to both human and avian influenza virus
infection. As evidenced by the expression of viral nucleoprotein,
190% of MDMs were infected by the 12-h POI. As is shown
in figure 1A, the expression of TNF-a mRNA was rapidly in-
duced by avian virus H9N2/G1 infection. It was detected at the
4-h POI and then gradually decreased over time. In contrast,
TRAIL mRNA expression in H9N2/G1-infected MDMs pro-
gressively increased with time (figure 1B). At all time points
assessed (the 4-, 8-, and 12-h POI), the expression level of
TRAIL mRNA in H9N2/G1-infected MDMs (range, 60–1000
copies/104 copies of b-actin) was significantly higher than that
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Figure 3. Release of functional soluble tumor necrosis factor–related
apoptosis-inducing ligand (TRAIL) by influenza virus–infected monocyte-
dervied macrophates (MDMs) that was cytotoxic to Jurkat T cells. UV-
irradiated supernatants from mock-treated (A) and influenza virus-infected
(B–D) MDMs were tested for cytotoxic activity against Jurkat T cells.
Jurkat T cells were incubated for 24 h with culture medium alone or
with 50% supernatant from mock- or H1N1/98-, H9N2/G1-, and H5N1/
97-infected MDMs, with or without TRAIL–receptor 2 (R2)/Fc chimera (1
mg/mL) or anti–Fas ligand (FasL; 1 mg/mL) ( , 4, 4, and 3, respec-np 4
tively). Cell death was determined by active caspase–3 staining. *P !
, ** )..05 P ! .01
in H1N1/98-infected MDMs (range, 10–100 copies/104 copies
of b-actin; ; ). A very low level of FasL mRNAnp 6 P ! .01
expression (!30 copies/104 copies of b-actin) was detected in
mock- or influenza virus–infected MDMs (figure 1C).
We subsequently repeated the experiment on H5N1/97-in-
fected MDMs in a biohazard level 3 laboratory. At the 7-h POI,
both TNF-a (figure 1D) and TRAIL (figure 1E) mRNA were
significantly up-regulated ( and , respectively,Pp .0289 Pp .01
vs. H1N1/98-infected MDMs; ), and the expression of FasLnp 4
was very low in H5N1/97-infected MDMs (figure 1F). This up-
regulation of TNF-a and TRAIL was dependent on viral repli-
cation. As is shown in figure 1D and 1E, a significantly lower
level of TNF-a and TRAIL mRNA expression was detected in
MDMs treated by UV-irradiated H5N1/97. The UV-irradiated
H5N1/97-induced TRAIL mRNA expression was, however, sig-
nificantly higher than that in mock-treated MDMs ( )Pp .001
(figure 1E). A similar pattern of TNF-a and TRAIL expression
was found in UV-treated H9N2/G1 virus (data not shown).
Release of soluble bioactive TNF-a and TRAIL from virus-
infected MDMs. Similar to that reported elsewhere [3], we
detected high levels of bioactive TNF-a in culture supernatant
from avian influenza virus–infected MDMs ( and4.43 0.38
ng/mL for H9N2/G1 and H5N1/97, respectively,5.28 1.34
vs. ng/mL for H1N1/98; ; ). In the0.53 0.28 P ! .001 np 4
search for a specific cell line to determine the release of bioactive
TRAIL by influenza virus–infected MDMs, we tested the sen-
sitivity of Jurkat T cells to recombinant DRLs. It was intriguing
to find that Jurkat T cells are sensitive to TRAIL and FasL in
a dose-dependent manner but not to TNF-a (figure 2A). This
specific induction of cell death by high-dose TRAIL (100 ng/
mL) and FasL (100 ng/mL) could be reversed by the addition
of TRAIL-R2/Fc chimera (1 mg/mL) and anti-FasL neutralizing
antibody (1 mg/mL), respectively (figure 2B).
By incubating Jurkat T cells in the presence of 50% UV-
irradiated supernatant, we demonstrated that supernatants from
H1N1/98-, H9N2/G1-, and H5N1/97-infected MDMs induced
the apoptosis of Jurkat T cells, but supernatants from mock-
treated MDMs did not (figure 3A–3D). The cell death could
be significantly reduced by the addition of TRAIL-R2/Fc chi-
mera but not by anti-FasL. The combination of both antibodies
did not reduce the level of apoptosis further.
Stronger apoptosis of Jurkat T cells infected by H1N1/98,
compared with H5N1/97 and H9N2/G1. To test the direct
cytopathic effects of influenza virus on Jurkat T cells, we in-
fected Jurkat T cells with the 3 virus strains at MOIs of 1. As
assessed by immunofluorescence staining of viral nucleoprotein
at the 24-h POI, 170% of Jurkat T cells were infected by either
human or avian influenza viruses. Marked apoptosis was de-
tected in H1N1/98-infected Jurkat T cells, with the percentage
of active caspase–3–positive cells at ( ;82.50% 1.1% np 3
figure 4). Fewer than 30% of apoptotic cells were detected in
H9N2/G1- and H5N1-infected Jurkat T cells (12.2%2.89%
and , respectively; ) (figure 4).22.2% 7.36% np 3
Direct induction of Jurkat T cells apoptosis by virus-infected
MDMs. It has been reported that the expression of TRAIL
on the surface of virus-infected cells is also important in in-
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Figure 4. Marked apoptosis of Jurkat T cells directly infected by human
influenza virus H1N1/98 but not by avian influenza viruses H9N2/G1 and
H5N1/97. Jurkat T cells were infected with H1N1/98, H5N1/97, and
H9N2/G1 at an MOI of 1 for 1 h; then, unadsorbed virus was washed
off and cells were cultured for further 24 h. Cell death was determined
by active caspase–3 staining. A high level of apoptosis was observed in
H1N1-infected Jurkat T cells. Data are the mean  SE from 3 inde-
pendent experiments.
Figure 5. Influenza virus-infected monocyte-dervied macrophates
(MDMs) becoming cytotoxic to Jurkat T cells. Mock- or virus-infected
MDMs were coincubated with PKH-26–labeled Jurkat T cells at a ratio
of 2:1. Cell death was determined by active caspase–3 staining (A and
B) The cytotoxicity of H1N1/98-infected MDMs ( ) and H9N2/G1-np 9
infected MDMs ( ) was significantly inhibited by tumor necrosisnp 14
factor–related apoptosis-inducing ligand (TRAIL)–receptor 2 (R2)/Fc chi-
mera (1 mg/mL) but not anti–Fas ligand (FasL; 1 mg/mL). C, Strong cy-
totoxicity in avian influenza virus H5N1/97–infected MDMs and Jurkat
T cell coculture. The apoptosis could only be reduced partially by TRAIL-
R2 Fc/chimera. Data are the mean  SE from 3 independent experiments.
* , ** .P ! .05 P ! .01
ducing apoptosis [14–16]. Hence, we tested the direct cyto-
toxicity of virus-infected MDMs by coculturing Jurkat T cells
with virus-infected MDMs for 24 h. No TPCK trypsin was
added, to ensure no infection of Jurkat T cells by H1N1/98 or
H9N2/G1 released from infected MDMs. The infection of cells
by H5N1/97 was, however, independent of the presence of tryp-
sin. Similar to that observed in MDM supernatant, increased
apoptosis was detected in Jurkat T cells cocultured with virus-
infected MDMs (figure 5). In contrast to H1N1/98- and H9N2/
G1-infected MDMs, H5N1/97-infected MDMs exhibited the
strongest induction of apoptosis in Jurkat T cells (figure 5C),
with the percentage of active caspase–3–positive cells at 55.30%
13.52% (vs. H9N2/G1 at and H1N1/98 at20.75% 2.12%
; and , respectively). The20.96% 3.78% Pp .0144 Pp .0485
cytotoxic effects of H1N1/98- and H9N2/G1-infected MDMs
on Jurkat T cells could be significantly inhibited by TRAIL-R2/
Fc chimera but not by anti-FasL alone (figure 5A and 5B).
Partial inhibition of apoptosis in Jurkat T cells cocultured with
H5N1/97-infected MDMs by TRAIL-R2/Fc chimera was ob-
served, but the difference did not yield statistical significance
(figure 5C).
Sensitization of Jurkat T cells by avian influenza viruses to
apoptosis induced by death receptor ligands. The stronger
induction of Jurkat T cells apoptosis by H5N1/97-infected
MDMs (figure 5C), compared with the corresponding UV-
treated supernatants (figure 3D), suggested that the effects of
virus itself may be involved. According to the virus titer mea-
sured in H5N1 coculture systems (105 log10 TCID50/mL), the
MOI in the coculture was only 0.2. Even when Jurkat T cells
were directly infected with H5N1 at an MOI of 1, the percentage
of active caspase–3–positive cells was not very high (figure 4).
Hence, there may be an increased sensitivity of Jurkat T cells
in the coculture system. To test the sensitivity of infected cells
to DRL-induced apoptosis, exogenous TNF-a (500 ng/mL),
TRAIL (10 ng/mL), or FasL (10 ng/mL) was added into H9N2/
G1- or H5N1/97-infected Jurkat T cells, and they were incu-
bated for 24 h. As shown in figure 6, mock-infected Jurkat T
cells were resistant to the apoptosis induction effect of TNF-
a, even at a high dose (500 ng/mL), and only a moderate
increase in apoptosis was observed with recombinant human
(rh) TRAIL and rhFasL. In contrast, a significantly enhanced
level of apoptosis was detected in H5N1/97- and H9N2/G1-
infected Jurkat T cells in the presence of TNF-a. A similar
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Figure 6. H9N2/G1 and H5N1/97 infection sensitizing Jurkat T cells to induction of apoptosis by tumor necrosis factor (TNF)–a, TNF-related
apoptosis-inducing ligand (TRAIL), and Fas ligand (FasL). After 1 h of virus adsorption, H9N2/G1- and H5N1/97-infected Jurkat T cells were cultured
in presence of exogenous TNF-a (500 ng/mL), TRAIL (10 ng/mL), or FasL (10 ng/mL), respectively, for another 24-h culture. A significantly higher per-
centage of apoptotic cells was observed ( ). Data are the mean  SE from 3 independent experiments.P ! .05
phenomenon was also observed with low doses of TRAIL and
FasL (figure 6).
DISCUSSION
Accelerated macrophage accumulation was detected in the
lungs of patients with fatal H5N1 disease [22] and in primates
[23], but their roles were not defined. Here, we used human
MDMs as an in vitro model and showed that influenza virus–
infected MDMs may exert a cytotoxic effect on lymphocytes.
In particular, we demonstrated that T cell apoptosis was me-
diated by functional TRAIL.
TRAIL, a member of the TNF superfamily, is involved in a
number of viral infections [12–16, 24, 25]. Its expression is up-
regulated directly by the binding of viral hemagglutinin (HA)
and neuraminidase of Newcastle virus to the target cells [26]
and by viral matrix protein of lyssavirus in the cytoplasm of
infected and transfected cells [27]. Alternatively, various cy-
tokines, including IFN-a, IFN-b, IFN-g, and TNF-a, can mod-
ulate the expression of TRAIL [28, 29]. In the present study,
we showed that avian influenza virus H9N2/G1 and H5N1/97
significantly up-regulated the expression of TNF-a and TRAIL,
but not FasL, in MDMs (figure 1A–1C). Because ∼90% of
MDMs were infected at the 12-h POI, the differential expression
caused by avian and human influenza viruses was not due to
the difference in infectivity. Our findings are supported by those
of recent studies that demonstrated that TRAIL was up-regu-
lated in avian influenza virus A/Bratislava/79 (H7N7)–infected
epithelial cells [30] and in NK cells and T cells of influenza
virus A/PR/8/34 (H1N1)–infected mice [31].
We also demonstrated that the induction of TNF-a and
TRAIL mRNA expression is dependent on viral replication.
Interestingly, UV-treated H5N1 virus could induce a low but
significant expression of TRAIL but not TNF-a mRNA in
MDMs (figure 1D and 1E). We have shown previously that the
high production of TNF-a in H5N1/97 infection was associ-
ated, at least in part, with the viral nonstructural protein [3].
Avian influenza virus H9N2/G1 and H5N1/97 share 6 common
internal genes. Their similar ability to induce DRLs suggested
that 1 of the internal genes or their proteins were likely to
be involved.
Consistent with our previous findings [3], there was abun-
dant production of bioactive TNF-a by avian influenza virus–
infected MDMs. To determine the mediator of apoptosis other
than TNF-a, we selected Jurkat T cells, which are only sensitive
to TRAIL- and FasL-mediated apoptosis (figure 2). We docu-
mented that the influenza virus–infected MDMs induced Jurkat
T cells apoptosis was specially mediated by TRAIL but not by
FasL (figures 3 and 5). It has been reported that Fas-FasL was
involved in the apoptosis of lymphocytes induced by human
influenza virus H1N1- and H3N2-infected monocytes through
direct cell-to-cell contact [32]. However, our experiments did
not indicate the involvement of FasL in the apoptosis of Jurkat
T cells induced by influenza virus–infected MDMs or its su-
pernatant (figures 3 and 5).
The influenza viruses used in the present study infected Jurkat
T cells to a similar extent; however, a lower level of apoptosis
was detected in avian than in human influenza infection (figure
4). Apoptosis induced by viral infection is a multifactor process
in which various influenza viral proteins are involved [33]. The
reduced cytopathic effects of avian viruses on Jurkat T cells sug-
gest a possible mechanism of immune evasion for avian viruses.
Although there was no significant difference in the level of
Jurkat T cell apoptosis when cells were exposed to the super-
natants from virus-infected MDMs (figure 3), H5N1/97-in-
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fected MDMs exhibited the strongest induction of Jurkat T cell
apoptosis via cell-to-cell contact (figure 5C). This higher level
of apoptosis in cell-to-cell coculture may be due to (1) direct
cytopathic effects caused by the virus, (2) enhanced responses
of infected cells to death signals, and/or (3) molecules other
than TRAIL.
The sensitization of avian influenza virus–infected Jurkat T
cells to apoptosis induced by TNF-a, TRAIL, and FasL was
observed in our experiments (figure 6). H5-subtype avian in-
fluenza virus has a characteristic cleavage-site sequence in the
viral HA that renders HA susceptible to the effect of a wide
spectrum of cellular proteases and permits H5N1 virus to be-
come infectious to many tissues and organs [34]. Therefore,
the sensitization to DRLs in the infected cells is probably com-
mon to many cell types in H5N1 infection and may contribute
to the severe lung damage or lymphopenia observed clinically.
Enhanced sensitization of virus-infected cells to apoptosis in-
duced by TRAIL or FasL has been reported in HIV, reovirus,
and respiratory syncytial virus [16, 35–37]. This is caused by
the up-regulation of TRAIL-R2 or Fas expression in virus-in-
fected cells that leads to enhanced TRAIL- and FasL-mediated
apoptosis. Other mechanisms that are responsible for the mod-
ulation of sensitivity or resistance to DRLs include the involve-
ment of TRAIL decoy receptors [38] and the regulation of
downstream molecules such as Fas-associated death domain
(FADD), caspase 8, cellular FADD-like IL-1b–converting en-
zyme inhibitory protein, and mitochondrial factors [39]. Fur-
ther study on the underlying mechanism is needed.
In addition to the induction of apoptosis [12–16, 24, 25,
40], TRAIL acts as an important immunomodulator. At an
early stage of influenza virus infection, TRAIL may suppress
immune responses [31]. It inhibits calcium influx and IL-2–
dependent growth in T cell blasts [41, 42] and enhances the
elimination of immature dendritic cells by NK cells in vivo
[43]. TRAIL has also been reported to enhance the propagation
of influenza virus in epithelial cells [30].
The recent episodes of human H5N1 infection—with high
mortality, notable lymphopenia, and thrombocytopenia [44]—
highlight the urgency to understand its pathogenesis. The pro-
duction of functional TRAIL and enhanced sensitization to
DRLs-induced apoptosis shown in the present study may con-
tribute to disease pathogenesis.
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